[The double-blind randomized placebo-controlled trial of N-acetylcysteine use in schizophrenia: preliminary results].

N-acetylcysteine has a positive effect on the negative, general psychopathology PANSS scores, some cognitive functions, in particular, working memory, that allows considering this drug as a promising method of augmentation of schizophrenia therapy and requires further attentive study.